| Media, News, Press Release

【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Prostate Cancer – Published in Cancers / Special Issue: Artificial Intelligence in Oncology –

Medmain Inc., a provider of the digital pathology support solutions “PidPort”, has successfully developed a pathological AI that enables to classify a prostate cancer with high accuracy in digital histopathology of transurethral resection specimens by using deep learning and transfer learning.
We are also pleased to announce that a paper on this development has been posted on Cancers, issued by MDPI (, and published in a special issue of Artificial Intelligence in Oncology on September 28, 2022.

*This achievement was made possible by a grant from the New Energy and Industrial Technology Development Organization (NEDO).